Agitation,Psychomotor

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

Physical Restraints in Intensive Care Unit Patients

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder

Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia

Clinical Trial on Agitation in Alzheimer's Dementia

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use

Outcomes of Antipsychotic Medication Used in the Emergency Department

Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients

Dronabinol for Agitation in Dementia Crossover Trial

A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.

Safe Brain Initiative, Operationalizing Precision Anaesthesia

Agitation Follow up After Introduction of a New Patient Care Algorithm

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Addressing Dementia Via Agitation-Centered Evaluation

The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation

CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial